Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

BIOQ:US

16.9500 USD 0.0500 0.29%

As of 20:10:00 ET on 03/27/2015.

Snapshot for BIOQUAL Inc (BIOQ)

Open: 16.9505 Day's Range: 16.9500 - 16.9505 Volume: 200
Previous Close: 17.0000 52wk Range: 8.0000 - 17.0500 1-Yr Rtn: -

Stock Chart for BIOQ

No chart data available.
  • BIOQ:US 16.9505
  • 1D
  • 1M
  • 1Y
17.0000
Interactive BIOQ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIOQ

Current P/E Ratio (ttm) 37.6667
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) 0.4500
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 14.96
Shares Outstanding (M) 0.88
30 Day Average Volume 1,244
Price/Book (mrq) 3.6910
Price/Sale (ttm) 0.6442
Dividend Indicated Gross Yield 1.18%
Cash Dividend (USD) 0.2000
Dividend Ex-Date 11/25/2014
5 Year Dividend Growth 4.56%
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIOQ

No data available

Company Profile & Key Executives for BIOQ

BIOQUAL, Inc. specializes in life sciences research involving the utilization of animal models. The Company provides its services to government and commercial contract clients. BIOQUAL conducts research on cancer and other diseases, develops veterinary therapeutics, conducts neurological testing for neurodegenerative disorders, and conducts other research.

John C LandonChairman/FounderMark G LewisPresident/CEO
David A NewcomerChief Financial OfficerMichael P O'FlahertyCOO/Secretary
More Company Profile & Key Executives for BIOQ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil